Jason Pitarresi to Molecular Targeted Therapy
This is a "connection" page, showing publications Jason Pitarresi has written about Molecular Targeted Therapy.
Connection Strength
0.031
-
Mace TA, Shakya R, Elnaggar O, Wilson K, Komar HM, Yang J, Pitarresi JR, Young GS, Ostrowski MC, Ludwig T, Bekaii-Saab T, Bloomston M, Lesinski GB. Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer. Oncotarget. 2015 Dec 29; 6(42):44509-22.
Score: 0.031